Guardion Health Sciences, which sells medical food and devices for retinal diseases, filed new terms for its upcoming IPO on Monday. The deal is expected to price in March.
The San Diego, CA-based company now plans to raise $7.5 million by offering 1.875 million shares at a price of $4 per share, where it would command a market cap of $90 million. The company previously filed in January to raise $8.7 million by offering 2.2 million shares at the same price, after filing its original terms just two days earlier (2.5mm share offering at a range of $3 to $4).
In its latest filing, Guardion Health Sciences also disclosed financial results for the 12 months ended December 31, 2018, and added joint bookrunner WestPark Capital and co-manager Univest Securities. WallachBeth Capital is still serving as lead left.
Guardion Health Sciences was founded in 2009 and booked $1 million in sales for the 12 months ended September 30, 2018. It plans to list on the NYSE under the symbol GHSI.
